PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3469

  1. 1,045 Posts.
    lightbulb Created with Sketch. 269
    Cant remember the original link but just found a couple more relating to the trademark for Zycosan which is owned by Dechra and a company called Sentio biosciences who I think may the company who developed the drug and possibly licenced it to Dechra.

    https://www.bizjournals.com/stlouis/news/2023/01/02/st-louis-area-firms-win-federal-approval-horse.html

    https://trademarks.justia.com/owners/dechra-limited-2883129/

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.